Celldex Therapeutics, Inc CLDX
$31.43
-0.85%
at last close
Market Cap$2.47 billion
P/E Ratio—
Div Yield—
Volume494.7K
52-Week Range
$17.85$35.79
Key Stats
- Today's Range
- $31.09 – $32.00
- 50-Day Range
- $27.92 – $35.79
- 52-Week Range
- $17.85 – $35.79
- Volume
- 495K shs
- Average Volume
- 742K shs
- Market Cap
- $2.47 billion
- P/E Ratio
- —
- Dividend Yield
- —
Valuation
- P/E Ratio
- —
- Price / Book
- 5.41
- Price / Sales
- 2848.74
Short Interest
- Short Interest
- 9.29%
- Days to Cover
- 6.86
Financials (TTM)
- Revenue
- $866,000
- Net Income
- $-283,646,000
- Net Margin
- -32753.58%
- Return on Equity
- -62.17%
- Debt-to-Equity
- —
About Celldex Therapeutics, Inc
Celldex Therapeutics Inc is a biopharmaceutical firm focused on mast cell biology and the development of therapeutic antibodies. Its pipeline includes monoclonal and bispecific antibodies aimed at treating severe inflammatory, allergic, autoimmune, and other mast cell-mediated diseases. The company operates in a single operating and reportable segment in the business of development, manufacturing and commercialization of novel therapeutics for human health care.
Related Stocks
Price and fundamental data are delayed and provided for informational purposes only. Not investment advice. See our disclaimer.